HomeCompareSNZZF vs DIVO

SNZZF vs DIVO: Dividend Comparison 2026

SNZZF yields 419.11% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNZZF wins by $16130.78M in total portfolio value
10 years
SNZZF
SNZZF
● Live price
419.11%
Share price
$0.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$16130.81M
Annual income
$10,978,099,643.81
Full SNZZF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — SNZZF vs DIVO

📍 SNZZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNZZFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNZZF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNZZF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNZZF
Annual income on $10K today (after 15% tax)
$35,624.48/yr
After 10yr DRIP, annual income (after tax)
$9,331,384,697.24/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, SNZZF beats the other by $9,331,383,862.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNZZF + DIVO for your $10,000?

SNZZF: 50%DIVO: 50%
100% DIVO50/50100% SNZZF
Portfolio after 10yr
$8065.42M
Annual income
$5,489,050,312.74/yr
Blended yield
68.06%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNZZF buys
0
DIVO buys
0
No recent congressional trades found for SNZZF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNZZFDIVO
Forward yield419.11%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$16130.81M$30.7K
Annual income after 10y$10,978,099,643.81$981.68
Total dividends collected$15662.62M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SNZZF vs DIVO ($10,000, DRIP)

YearSNZZF PortfolioSNZZF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$52,611$41,911.15$11,349$649.42+$41.3KSNZZF
2$262,368$206,074.17$12,833$688.83+$249.5KSNZZF
3$1,241,180$960,446.19$14,459$727.90+$1.23MSNZZF
4$5,574,386$4,246,322.91$16,238$766.49+$5.56MSNZZF
5$23,788,030$17,823,436.96$18,179$804.47+$23.77MSNZZF
6$96,536,747$71,083,555.25$20,293$841.71+$96.52MSNZZF
7$372,894,112$269,599,792.82$22,591$878.14+$372.87MSNZZF
8$1,372,256,180$973,259,480.12$25,087$913.65+$1372.23MSNZZF
9$4,815,613,318$3,347,299,205.73$27,791$948.18+$4815.59MSNZZF
10$16,130,805,894$10,978,099,643.81$30,718$981.68+$16130.78MSNZZF

SNZZF vs DIVO: Complete Analysis 2026

SNZZFStock

Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.

Full SNZZF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this SNZZF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNZZF vs SCHDSNZZF vs JEPISNZZF vs OSNZZF vs KOSNZZF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.